)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Jiangsu Nhwa Pharmaceutical
Jiangsu Nhwa Pharmaceutical (002262) investor relations material
Jiangsu Nhwa Pharmaceutical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary17 Aug, 2026
Executive summary
Revenue for H1 2026 reached ¥3.22 billion, up 6.91% year-over-year, with net profit attributable to shareholders at ¥740.68 million, up 5.74% year-over-year.
Core business remains focused on CNS drugs, with strong R&D pipeline and market leadership in anesthesia, pain, and psychiatric medications.
Significant investments in digitalization, production capacity, and talent development supported operational efficiency and innovation.
Financial highlights
Operating income: ¥3.22 billion (+6.91% YoY); net profit: ¥740.68 million (+5.74% YoY).
Gross margin for anesthesia products: 91.67%; psychiatric: 76.54%; neurology: 63.00%.
Cash flow from operations: ¥280.41 million, down 43.33% YoY due to increased cash outflows for purchases.
R&D investment: ¥385.30 million, representing 12% of revenue.
Total assets at period end: ¥9.54 billion (+3.38% from year-end 2025).
Outlook and guidance
Continued focus on CNS drug innovation and market expansion, leveraging digital and precision medicine.
Plans to accelerate new product launches and expand into emerging therapeutic areas.
Ongoing investment in R&D and digital transformation to sustain growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jiangsu Nhwa Pharmaceutical
- Revenue up 3.75%, net profit down 7.54%, strong R&D and cash flow, dividend proposed.002262
H2 2025 - Revenue and net profit rose year-over-year, but operating cash flow declined sharply.002262Q1 2026
- Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectively.002262Q3 2025
- Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth.002262H1 2025
- Q3 2024 saw double-digit revenue and profit growth, with robust cash flow and rising EPS.002262Q3 2024
- H1 revenue and net profit rose 15%+ on CNS drug growth and robust R&D pipeline.002262H1 2024
- 2024 revenue and net profit rose double digits, with strong CNS drug and digital health growth.002262H2 2024
- Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returns.002262Q1 2025
Next Jiangsu Nhwa Pharmaceutical earnings date
Q3 202626 Oct, 2026
Jiangsu Nhwa Pharmaceutical
Next Jiangsu Nhwa Pharmaceutical earnings date
Q3 202626 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage